Sally Beauty Inc. (SBH)
NYSE: SBH
· Real-Time Price · USD
8.71
-0.58 (-6.24%)
At close: May 21, 2025, 3:59 PM
8.67
-0.40%
Pre-market: May 22, 2025, 07:32 AM EDT
Sally Beauty Revenue Breakdown
| Period Ending | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | Sep 30, 2015 | Sep 30, 2014 | Sep 30, 2013 | Sep 30, 2012 | Sep 30, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beauty Systems Group Revenue | 1.61B | 1.59B | 1.62B | 1.6B | 1.43B | 1.58B | 1.6B | 1.59B | 1.59B | 1.5B | 1.44B | 1.39B | 1.33B | 1.26B |
| Beauty Systems Group Revenue Growth | +1.32% | -2.07% | +1.62% | +11.37% | -9.45% | -0.96% | +0.35% | +0.32% | +5.53% | +4.16% | +3.78% | +5.06% | +5.45% | n/a |
| Sally Beauty Supply Revenue | 2.11B | 2.14B | 2.19B | 2.28B | 2.08B | 2.29B | 2.33B | 2.35B | 2.36B | 2.33B | 2.31B | 2.23B | 2.2B | 2.01B |
| Sally Beauty Supply Revenue Growth | -1.50% | -2.45% | -3.75% | +9.50% | -9.26% | -1.75% | -0.48% | -0.82% | +1.50% | +0.90% | +3.53% | +1.44% | +9.25% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 389.44M | 376.52M | 397.37M | 408.73M | 376.48M | 398.14M | 390.53M | 384.18M | 389.66M | 391.58M | 397.87M | 390.96M | 378.87M | 386.25M | 386.54M | 386.48M | 391.09M | 366.17M | 366.98M | 314.6M | 383.3M | 377.93M | 363.95M | 360.18M | 361.63M | 366.99M | 365.86M | 378.6M | 368.46M | 371.29M | 333.91M | 337.99M | 331.98M | 347.41M | 345.49M | 339.46M | 341.31M | 339.73M | 330.86M | 327.87M | 317.46M |
| Selling, General, and Administrative Revenue Growth | +3.43% | -5.25% | -2.78% | +8.57% | -5.44% | +1.95% | +1.65% | -1.40% | -0.49% | -1.58% | +1.77% | +3.19% | -1.91% | -0.08% | +0.02% | -1.18% | +6.80% | -0.22% | +16.65% | -17.92% | +1.42% | +3.84% | +1.05% | -0.40% | -1.46% | +0.31% | -3.36% | +2.75% | -0.76% | +11.19% | -1.21% | +1.81% | -4.44% | +0.56% | +1.78% | -0.54% | +0.47% | +2.68% | +0.91% | +3.28% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |